Improve Medical Instruments Co., Ltd. Stock price

Equities

300030

CNE100000JL3

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
5.52 CNY +2.41% Intraday chart for Improve Medical Instruments Co., Ltd. -5.96% -28.77%
Sales 2021 800M 111M Sales 2022 711M 98.41M Capitalization 2.13B 295M
Net income 2021 18M 2.49M Net income 2022 -198M -27.41M EV / Sales 2021 4.34 x
Net Debt 2021 179M 24.8M Net Debt 2022 202M 28M EV / Sales 2022 3.28 x
P/E ratio 2021
178 x
P/E ratio 2022
-10.8 x
Employees 1,069
Yield 2021
0.38%
Yield 2022
-
Free-Float 60.22%
More Fundamentals * Assessed data
Dynamic Chart
Improve Medical Instruments Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Improve Medical Instruments Co., Ltd. cancelled the transaction announced on June 28, 2023 CI
Improve Medical Instruments Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Improve Medical Instruments Co., Ltd. announced that it expects to receive CNY 156 million in funding CI
Improve Medical Instruments Co., Ltd. Announces Board Elections CI
Improve Medical Instruments Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Improve Medical Instruments Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Kaiyuan Investment Co., Ltd. acquired 83.33% stake in Yizhang Luojia Hospital Management Co., Ltd. from Improve Medical Instruments Co., Ltd.. CI
Improve Medical Instruments Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Improve Medical Instruments Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Improve Medical Instruments Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 06, 2022 CI
Improve Medical Instruments Co., Ltd. Approves Cash Dividend for 2021 CI
Improve Medical Instruments Co., Ltd. Announces Final Dividend for 2021 CI
Improve Medical Instruments Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Improve Medical Instruments Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day+2.41%
1 week-5.96%
Current month+7.60%
1 month+10.62%
3 months-28.03%
6 months-27.84%
Current year-28.77%
More quotes
1 week
5.30
Extreme 5.3
5.73
1 month
4.82
Extreme 4.82
6.11
Current year
3.44
Extreme 3.44
7.97
1 year
3.44
Extreme 3.44
9.34
3 years
3.44
Extreme 3.44
13.39
5 years
3.44
Extreme 3.44
16.63
10 years
3.44
Extreme 3.44
38.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 07-10-25
Director of Finance/CFO 60 10-10-21
Director/Board Member 38 21-12-30
Members of the board TitleAgeSince
Chief Executive Officer 58 07-10-25
Director/Board Member 55 20-06-09
Director/Board Member 58 06-05-31
More insiders
Date Price Change Volume
24-03-28 5.52 +2.41% 8,607,602
24-03-27 5.39 -1.28% 7,174,500
24-03-26 5.46 +0.18% 7,679,100
24-03-25 5.45 -4.55% 8,747,898
24-03-22 5.71 -2.73% 10,874,990

End-of-day quote Shenzhen S.E., March 27, 2024

More quotes
Improve Medical Instruments Co Ltd, formerly Guangzhou Improve Medical Instruments Co Ltd, is a China-based company mainly engaged in the production and sales of medical equipment. The Company is also engaged in the financial leasing business of medical equipment. The Company's products include vacuum blood collection systems, liquid biopsy tubes, automatic blood collection tube detachers, thromboelastometers and reagents, hospital intelligent blood collection management systems, sub-medical record systems (EMR) and others. The Company's products also include masks, instruments, reagents and others. The Company's products are exported to Russia, Saudi Arabia, Brazil, South Korea and other countries and regions.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Improve Medical Instruments Co., Ltd. - Shenzhen S.E.